1-13 of 13
Shun Ishibashi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study

Hiroshi Itoh, Issei Komuro, Masahiro Takeuchi, Takashi Akasaka, Hiroyuki Daida, Yoshiki Egashira, Hideo Fujita, Jitsuo Higaki, Ken-ichi Hirata, Shun Ishibashi, Takaaki Isshiki, Sadayoshi Ito, Atsunori Kashiwagi, Satoshi Kato, Kazuo Kitagawa, Masafumi Kitakaze, Takanari Kitazono, Masahiko Kurabayashi, Katsumi Miyauchi, Tomoaki Murakami, Toyoaki Murohara, Koichi Node, Susumu Ogawa, Yoshihiko Saito, Yoshihiko Seino, Takashi Shigeeda, Shunya Shindo, Masahiro Sugawara, Seigo Sugiyama, Yasuo Terauchi, Hiroyuki Tsutsui, Kenji Ueshima, Kazunori Utsunomiya, Masakazu Yamagishi, Tsutomu Yamazaki, Shoei Yo, Koutaro Yokote, Kiyoshi Yoshida, Michihiro Yoshimura, Nagahisa Yoshimura, Kazuwa Nakao, Ryozo Nagai
Journal: Diabetes Care
Diabetes Care 2018;41(6):1275–1284
https://doi.org/10.2337/dc17-2224
Published: 06 April 2018
View article titled, Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study
Open the PDF for Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study in another window
Includes: Supplementary data
Journal Articles

Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial

Eiichi Araki, Shizuya Yamashita, Hidenori Arai, Koutaro Yokote, Jo Satoh, Toyoshi Inoguchi, Jiro Nakamura, Hiroshi Maegawa, Narihito Yoshioka, Yukio Tanizawa, Hirotaka Watada, Hideki Suganami, Shun Ishibashi
Journal: Diabetes Care
Diabetes Care 2018;41(3):538–546
https://doi.org/10.2337/dc17-1589
Published: 03 January 2018
View article titled, Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial
Open the PDF for Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial in another window
Includes: Supplementary data
Journal Articles

Comparison of Various Lipid Variables as Predictors of Coronary Heart Disease in Japanese Men and Women With Type 2 Diabetes: Subanalysis of the Japan Diabetes Complications Study

Hirohito Sone, MD, Sachiko Tanaka, PHD, Shiro Tanaka, PHD, Satoshi Iimuro, MD, Shun Ishibashi, MD, Shinichi Oikawa, MD, Hitoshi Shimano, MD, Shigehiro Katayama, MD, Yasuo Ohashi, PHD, Yasuo Akanuma, MD, Nobuhiro Yamada, MD, on behalf of the Japan Diabetes Complications Study Group
Journal: Diabetes Care
Diabetes Care 2012;35(5):1150–1157
https://doi.org/10.2337/dc11-1412
Published: 11 April 2012
View article titled, Comparison of Various Lipid Variables as Predictors of Coronary Heart Disease in Japanese Men and Women With Type 2 Diabetes: <subtitle>Subanalysis of the Japan Diabetes Complications Study</subtitle>
Open the PDF for Comparison of Various Lipid Variables as Predictors of Coronary Heart Disease in Japanese Men and Women With Type 2 Diabetes: <subtitle>Subanalysis of the Japan Diabetes Complications Study</subtitle> in another window
Includes: Supplementary data
Journal Articles

New Insights on the Simultaneous Assessment of Insulin Sensitivity and β-Cell Function With the HOMA2 Method: Response to Caumo et al.

Shoichiro Nagasaka, MD, Naoko Sato, MD, Nirei Takahashi, MD, Ikuyo Kusaka, MD, Shun Ishibashi, MD
Journal: Diabetes Care
Diabetes Care 2007;30(5):e42
https://doi.org/10.2337/dc07-0016
Published: 01 May 2007
View article titled, New Insights on the Simultaneous Assessment of Insulin Sensitivity and β-Cell Function With the HOMA2 Method: <subtitle>Response to Caumo et al.</subtitle>
Open the PDF for New Insights on the Simultaneous Assessment of Insulin Sensitivity and β-Cell Function With the HOMA2 Method: <subtitle>Response to Caumo et al.</subtitle> in another window
Journal Articles

The New Worldwide Definition of Metabolic Syndrome Is Not a Better Diagnostic Predictor of Cardiovascular Disease in Japanese Diabetic Patients Than the Existing Definitions : Additional analysis from the Japan Diabetes Complications Study

Hirohito Sone, MD, PHD, FACP, Sachiko Tanaka, PHD, Shun Ishibashi, MD, PHD, Yoshimitsu Yamasaki, MD, PHD, Shinichi Oikawa, MD, PHD, Hideki Ito, MD, PHD, Yasushi Saito, MD, PHD, Yasuo Ohashi, PHD, Yasuo Akanuma, MD, PHD, Nobuhiro Yamada, MD, PHD, for the Japan Diabetes Complications Study (JDCS) Group
Journal: Diabetes Care
Diabetes Care 2006;29(1):145–147
https://doi.org/10.2337/diacare.29.01.06.dc05-1341
Published: 01 January 2006
View article titled, The New Worldwide Definition of Metabolic Syndrome Is Not a Better Diagnostic Predictor of Cardiovascular Disease in Japanese Diabetic Patients Than the Existing Definitions : <subtitle>Additional analysis from the Japan Diabetes Complications Study</subtitle>
Open the PDF for The New Worldwide Definition of Metabolic Syndrome Is Not a Better Diagnostic Predictor of Cardiovascular Disease in Japanese Diabetic Patients Than the Existing Definitions : <subtitle>Additional analysis from the Japan Diabetes Complications Study</subtitle> in another window
Journal Articles

Is the Diagnosis of Metabolic Syndrome Useful for Predicting Cardiovascular Disease in Asian Diabetic Patients?: Analysis from the Japan Diabetes Complications Study

Hirohito Sone, MD, PHD, FACP, Sachiko Mizuno, PHD, Hitomi Fujii, MD, Yukio Yoshimura, PHD, RD, Yoshimitsu Yamasaki, MD, PHD, Shun Ishibashi, MD, PHD, Shigehiro Katayama, MD, PHD, Yasushi Saito, MD, PHD, Hideki Ito, MD, PHD, Yasuo Ohashi, PHD, Yasuo Akanuma, MD, PHD, Nobuhiro Yamada, MD, PHD, the Japan Diabetes Complications Study Group
Journal: Diabetes Care
Diabetes Care 2005;28(6):1463–1471
https://doi.org/10.2337/diacare.28.6.1463
Published: 01 June 2005
View article titled, Is the Diagnosis of Metabolic Syndrome Useful for Predicting Cardiovascular Disease in Asian Diabetic Patients?: <subtitle>Analysis from the Japan Diabetes Complications Study</subtitle>
Open the PDF for Is the Diagnosis of Metabolic Syndrome Useful for Predicting Cardiovascular Disease in Asian Diabetic Patients?: <subtitle>Analysis from the Japan Diabetes Complications Study</subtitle> in another window
Journal Articles

Glimepiride and Serum Adiponectin Level in Type 2 Diabetic Subjects: Response to Yoshioka, Yoshida, and Yoshikawa

Shoichiro Nagasaka, MD, Ataru Taniguchi, MD, Yoshitaka Aiso, MD, Toshimitsu Yatagai, MD, Tomoatsu Nakamura, MD, Yoshikatsu Nakai, MD, Mitsuo Fukushima, MD, Akira Kuroe, MD, Shun Ishibashi, MD
Journal: Diabetes Care
Diabetes Care 2003;26(12):3361
https://doi.org/10.2337/diacare.26.12.3361
Published: 01 December 2003
View article titled, Glimepiride and Serum Adiponectin Level in Type 2 Diabetic Subjects: <subtitle>Response to Yoshioka, Yoshida, and Yoshikawa</subtitle>
Open the PDF for Glimepiride and Serum Adiponectin Level in Type 2 Diabetic Subjects: <subtitle>Response to Yoshioka, Yoshida, and Yoshikawa</subtitle> in another window
Journal Articles

Effect of Glimepiride on Serum Adiponectin Level in Subjects With Type 2 Diabetes

Shoichiro Nagasaka, MD, Ataru Taniguchi, MD, Yoshitaka Aiso, MD, Toshimitsu Yatagai, MD, Tomoatsu Nakamura, MD, Yoshikatsu Nakai, MD, Mitsuo Fukushima, MD, Akira Kuroe, MD, Shun Ishibashi, MD
Journal: Diabetes Care
Diabetes Care 2003;26(7):2215–2216
https://doi.org/10.2337/diacare.26.7.2215
Published: 01 July 2003
View article titled, Effect of Glimepiride on Serum Adiponectin Level in Subjects With Type 2 Diabetes
Open the PDF for Effect of Glimepiride on Serum Adiponectin Level in Subjects With Type 2 Diabetes in another window
Journal Articles

HLA-DR-DQ Haplotype in Rapid-Onset Type 1 Diabetes in Japanese

Tomoatsu Nakamura, MD, Shoichiro Nagasaka, MD, Ikuyo Kusaka, MD, Toshimitsu Yatagai, MD, Jianmei Yang, MD, Shun Ishibashi, MD
Journal: Diabetes Care
Diabetes Care 2003;26(5):1640–1641
https://doi.org/10.2337/diacare.26.5.1640
Published: 01 May 2003
View article titled, HLA-DR-DQ Haplotype in Rapid-Onset Type 1 Diabetes in Japanese
Open the PDF for HLA-DR-DQ Haplotype in Rapid-Onset Type 1 Diabetes in Japanese in another window
Journal Articles

The Long-Term Effects of Self-Management Education for Patients With Type 2 Diabetes on Glycemic Control: Response to Norris et al.

Hirohito Sone, MD, PhD, FACP, Hideki Ito, MD, PHD, Yasushi Saito, MD, PHD, Hidetoshi Yamashita, MD, PHD, Shun Ishibashi, MD, PHD, Shigehiro Katayama, MD, PHD, Ryuzo Abe, MD, PHD, Yasuo Ohashi, PHD, Yasuo Akanuma, MD, PHD, Nobuhiro Yamada, MD, PHD, Japan Diabetes Complication Study Group
Journal: Diabetes Care
Diabetes Care 2002;25(11):2115–2116
https://doi.org/10.2337/diacare.25.11.2115
Published: 01 November 2002
View article titled, The Long-Term Effects of Self-Management Education for Patients With Type 2 Diabetes on Glycemic Control: <subtitle>Response to Norris et al. </subtitle>
Open the PDF for The Long-Term Effects of Self-Management Education for Patients With Type 2 Diabetes on Glycemic Control: <subtitle>Response to Norris et al. </subtitle> in another window
Journal Articles

Obesity Is a Critical Risk Factor for Worsening of Glucose Tolerance in a Family With the Mutant Insulin Receptor

Akihiko Ando, MD, Toshimitsu Yatagai, MD, Kumiko Rokkaku, MD, Shoichiro Nagasaka, MD, San-e Ishikawa, MD, Shun Ishibashi, MD
Journal: Diabetes Care
Diabetes Care 2002;25(8):1484–1485
https://doi.org/10.2337/diacare.25.8.1484
Published: 01 August 2002
View article titled, Obesity Is a Critical Risk Factor for Worsening of Glucose Tolerance in a Family With the Mutant Insulin Receptor
Open the PDF for Obesity Is a Critical Risk Factor for Worsening of Glucose Tolerance in a Family With the Mutant Insulin Receptor in another window
Journal Articles

Improved Glycemic Control in a Diabetic Patient After Discontinuation of Allopurinol Administration

Ken Ohashi, MD, Shun Ishibashi, MD, Yoshio Yazaki, MD, Nobuhiro Yamada, MD
Journal: Diabetes Care
Diabetes Care 1998;21(1):192–193
https://doi.org/10.2337/diacare.21.1.192
Published: 01 January 1998
View article titled, Improved Glycemic Control in a Diabetic Patient After Discontinuation of Allopurinol Administration
Open the PDF for Improved Glycemic Control in a Diabetic Patient After Discontinuation of Allopurinol Administration in another window
Journal Articles

Apolipoprotein E Polymorphism Is Associated With Plasma Cholesterol Response in a 7-day Hospitalization Study for Metabolic and Dietary Control in NIDDM

Kaori Murakami, PHD, Mizuo Shimizu, MD, Nobuhiro Yamada, MD, Shun Ishibashi, MD, Hitoshi Shimano, MD, Yoshio Yazaki, MD, Yasuo Akanuma, MD
Journal: Diabetes Care
Diabetes Care 1993;16(4):564–569
https://doi.org/10.2337/diacare.16.4.564
Published: 01 April 1993
View article titled, Apolipoprotein E Polymorphism Is Associated With Plasma Cholesterol Response in a 7-day Hospitalization Study for Metabolic and Dietary Control in NIDDM
Open the PDF for Apolipoprotein E Polymorphism Is Associated With Plasma Cholesterol Response in a 7-day Hospitalization Study for Metabolic and Dietary Control in NIDDM in another window